Diabetes will be history
A research done at the University of Minnesota has been very successful. A group of scientists, lead by Brandon Nathan, are set to launch a clinical phase for their process of using stem cells to “kill” Type-I diabetes.
In simple terms, type-I diabetes means that the pancreas can’t produce enough insulin. In this clinical trial, stem cells will be injected in people who suffer from this kind of diabetes. Of course, we’re talking about adult stem cells, which have been proven to be able to repair tissue. Researchers are hoping that they will also be able to repair pancreatic cells.
This trial is actually based on numerous researchers done on laboratory mice. The leader of the crew, Mr. Nathan, says that he hopes that the trial will result in a positive way. “There were many drugs that were successful in mice, but failed when treated on humans. So this is not yet a sure thing. We’ll see what happens.”
Pancreas is a gland organ. It is both an endocrine and exocrine gland, producing pancreatic juice which contains many enzymes that help in “breaking” carbohydrates, proteins and fats.
Subscribe to the comments for this post